Fused pyrimidine derivatives for inhibition of tyrosine kinase activity

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO RE46511
SERIAL NO

15099171

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a novel fused pyrimidine derivative having an inhibitory activity for tyrosine kinases, and a pharmaceutical composition for preventing or treating cancers, tumors, inflammatory diseases, autoimmune diseases, or immunologically mediated diseases comprising same as an active ingredient.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
HANMI SCIENCE CO LTD214 MUHA-RO PALTAN-MYEON GYEONGGI-DO HWASEONG-SI 18536

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cha, Mi Young Seongnam-si, KR 18 106
Ha, Tae Hee Hwaseong-si, KR 25 63
Jeon, Ji Young Gunpo-si, KR 7 50
Jo, Myoung Gi Anyang-si, KR 4 49
Kang, Seok Jong Okcheon-gun, KR 10 51
Kim, Maeng Sup Seoul, KR 23 148
Kim, Mi Ra Seoul, KR 10 92
Kwak, Eun Joo Seogwipo-si, KR 10 83
Lee, Ju Yeon Gwangju, KR 30 145
Lee, Kwang Ok Yongin-si, KR 9 53
Suh, Kwee Hyun Suwon-si, KR 43 97

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Feb 15, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 15, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00